New SPAC: Drugs Made In America Acquisition Corp. (DMAAU) Files for $500M IPO

Drugs Made In America (NASDAQ:DMAAU) has filed for a $500 million IPO, which would make it underwriter EF Hutton’s largest SPAC to date. The next largest SPAC in EF Hutton’s portfolio is half as large and this could mark a new aggressiveness by the underwriter as the SPAC market heats up this summer, although EF
Read More